Dual-Use Biodefense Applications
CLOAK engineers the skin's native microbiome into a long-duration barrier against disease-vector insects, built to satisfy civilian regulatory standards and defense-grade reliability requirements alike.
Expanding vector habitat range, driven by climate shift, continues to increase exposure risk across both civilian and operational populations.
CLOAK is engineered as a candidate addition to the global malaria-eradication toolkit, operating alongside case management, vector control strategies, and vaccines.
Engineered for continuous operational environments and designed to meet U.S. Department of War and NATO mission-readiness standards, without dependence on manual reapplication cycles.
CLOAK engineers naturally occurring, non-pathogenic skin bacteria to modify the chemical signals mosquitoes use for host detection. Protection is engineered at the source of attraction, not by masking with topical chemical agents.
A single application maintains verified efficacy for eleven or more days in in vivo animal studies.
No active chemical agents, no residue, no detectable scent profile.
Verified efficacy across the Aedes, Anopheles, and Culex genera, plus sandflies.
CLOAK's founding team originates from the DARPA ReVector Program.
